{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:50:08Z","timestamp":1792673408306,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T00:00:00Z","timestamp":1706227200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016574","name":"JSPA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016574","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K09064"],"award-info":[{"award-number":["20K09064"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K08966"],"award-info":[{"award-number":["20K08966"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K16338"],"award-info":[{"award-number":["20K16338"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19K23923"],"award-info":[{"award-number":["19K23923"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["145"],"award-info":[{"award-number":["145"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K07223"],"award-info":[{"award-number":["21K07223"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K09457"],"award-info":[{"award-number":["22K09457"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["143"],"award-info":[{"award-number":["143"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22H04925"],"award-info":[{"award-number":["22H04925"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["133"],"award-info":[{"award-number":["133"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K09353"],"award-info":[{"award-number":["21K09353"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jmdjournal.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jmoldx.2024.01.006","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T12:51:36Z","timestamp":1706791896000},"page":"278-291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["The Clinical Validity of Urinary Pellet DNA Monitoring for the Diagnosis of Recurrent Bladder Cancer"],"prefix":"10.1016","volume":"26","author":[{"given":"Masakazu","family":"Abe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1282-9898","authenticated-orcid":false,"given":"Hayato","family":"Hiraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Tsuyukubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadahide","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4620-2831","authenticated-orcid":false,"given":"Shigekatsu","family":"Maekawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daichi","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Yashima-Abo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6089-7620","authenticated-orcid":false,"given":"Renpei","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromitsu","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Iwaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woong-Yang","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Idogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Tokino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Obara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi S.","family":"Nishizuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmoldx.2024.01.006_bib1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European Association of Urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.jmoldx.2024.01.006_bib2","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1002\/cncr.28147","article-title":"Recurrence of high-risk bladder cancer: a population-based analysis","volume":"119","author":"Chamie","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.jmoldx.2024.01.006_bib3","doi-asserted-by":"crossref","first-page":"329","DOI":"10.6004\/jnccn.2020.0011","article-title":"Bladder cancer, version 3.2020, NCCN clinical practice guidelines in oncology","volume":"18","author":"Flaig","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.jmoldx.2024.01.006_bib4","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.annonc.2021.11.012","article-title":"Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"33","author":"Powles","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jmoldx.2024.01.006_bib5","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1038\/modpathol.2008.193","article-title":"Diagnosis of urothelial carcinoma from urine","volume":"22","author":"T\u00eatu","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jmoldx.2024.01.006_bib6","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.urolonc.2010.09.009","article-title":"Fluorescence and white light cystoscopy for detection of carcinoma in situ of the urinary bladder","volume":"30","author":"Lerner","year":"2012","journal-title":"Urol Oncol"},{"key":"10.1016\/j.jmoldx.2024.01.006_bib7","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0022-5347(01)67054-X","article-title":"Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancer","volume":"154","author":"Sarosdy","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.jmoldx.2024.01.006_bib8","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0022-5347(01)65851-8","article-title":"Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment","volume":"156","author":"Soloway","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.jmoldx.2024.01.006_bib9","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1159\/000020318","article-title":"Urinary BTA-stat, BTA-trak and NMP22 in surveillance after TUR of recurrent superficial transitional cell carcinoma of the bladder","volume":"38","author":"Serretta","year":"2000","journal-title":"Eur Urol"},{"key":"10.1016\/j.jmoldx.2024.01.006_bib10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2016.01.007","article-title":"Genomic alterations in liquid biopsies from patients with bladder cancer","volume":"70","author":"Birkenkamp-Demtr\u00f6der","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.jmoldx.2024.01.006_bib11","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1158\/2159-8290.CD-18-0825","article-title":"Detection and surveillance of bladder cancer using urine tumor DNA","volume":"9","author":"Dudley","year":"2019","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jmoldx.2024.01.006_bib12","article-title":"Urine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy: a cohort study","volume":"18","author":"Chauhan","year":"2021","journal-title":"PLoS Med"},{"key":"10.1016\/j.jmoldx.2024.01.006_bib13","doi-asserted-by":"crossref","first-page":"5554","DOI":"10.1038\/s41598-017-05623-3","article-title":"Association of plasma and urinary mutant DNA with clinical outcomes in muscle invasive bladder cancer","volume":"7","author":"Patel","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jmoldx.2024.01.006_bib14","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.eururo.2017.09.011","article-title":"Monitoring treatment response and metastatic relapse in advanced bladder cancer by liquid biopsy analysis","volume":"73","author":"Birkenkamp-Demtroder","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.jmoldx.2024.01.006_bib15","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.euo.2022.03.005","article-title":"Highly sensitive and specific detection of bladder cancer via targeted ultra-deep sequencing of urinary DNA","volume":"6","author":"Ward","year":"2022","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.jmoldx.2024.01.006_bib16","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.eururo.2016.12.016","article-title":"Liquid biopsy analysis of FGFR3 and PIK3CA hotspot mutations for disease surveillance in bladder cancer","volume":"71","author":"Christensen","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.jmoldx.2024.01.006_bib17","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/ejhg.2015.281","article-title":"Genomic complexity of urothelial bladder cancer revealed in urinary cfDNA","volume":"24","author":"Togneri","year":"2016","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jmoldx.2024.01.006_bib18","article-title":"Correction: non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy","volume":"7","author":"Springer","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.jmoldx.2024.01.006_bib19","article-title":"Emerging roles of urine-based tumor DNA analysis in bladder cancer management","volume":"4","author":"Chaudhuri","year":"2020","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.jmoldx.2024.01.006_bib20","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1200\/JCO.2017.76.8671","article-title":"Circulating tumor DNA analysis in patients with cancer: American Society of Clinical Oncology and College of American Pathologists joint review","volume":"36","author":"Merker","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2024.01.006_bib21","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1053\/j.gastro.2020.09.035","article-title":"Frequent tumor burden monitoring of esophageal squamous cell carcinoma with circulating tumor DNA using individually designed digital polymerase chain reaction","volume":"160","author":"Iwaya","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jmoldx.2024.01.006_bib22","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jmoldx.2016.06.003","article-title":"Clinical validity and utility: putting the patient front and center","volume":"18","author":"Farkas","year":"2016","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2024.01.006_bib23","article-title":"Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy","volume":"7","author":"Springer","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.jmoldx.2024.01.006_bib24","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13059-019-1659-6","article-title":"Analysis of error profiles in deep next-generation sequencing data","volume":"20","author":"Ma","year":"2019","journal-title":"Genome Biol"},{"key":"10.1016\/j.jmoldx.2024.01.006_bib25","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12920-021-01040-8","article-title":"Characterization of DNA lesions associated with cell-free DNA by targeted deep sequencing","volume":"14","author":"Shin","year":"2021","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.jmoldx.2024.01.006_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0239966","article-title":"Analysis of mutational and proteomic heterogeneity of gastric cancer suggests an effective pipeline to monitor post-treatment tumor burden using circulating tumor DNA","volume":"15","author":"Sasaki","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jmoldx.2024.01.006_bib27","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1038\/s41416-021-01266-4","article-title":"Frequent post-operative monitoring of colorectal cancer using individualised ctDNA validated by multiregional molecular profiling","volume":"124","author":"Yaegashi","year":"2021","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jmoldx.2024.01.006_bib28","doi-asserted-by":"crossref","first-page":"9236","DOI":"10.1073\/pnas.96.16.9236","article-title":"Digital PCR","volume":"96","author":"Vogelstein","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jmoldx.2024.01.006_bib29","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1001\/jamaoncol.2019.0528","article-title":"Analysis of plasma cell-free DNA by ultradeep sequencing in patients with stages I to III colorectal cancer","volume":"5","author":"Reinert","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jmoldx.2024.01.006_bib30","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2012.45.2011","article-title":"Liquid biopsies: genotyping circulating tumor DNA","volume":"32","author":"Diaz","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2024.01.006_bib31","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/bju.14808","article-title":"Targeted deep sequencing of urothelial bladder cancers and associated urinary DNA: a 23-gene panel with utility for non-invasive diagnosis and risk stratification","volume":"124","author":"Ward","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.jmoldx.2024.01.006_bib32","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.eururo.2017.05.032","article-title":"Next-generation sequencing of nonmuscle invasive bladder cancer reveals potential biomarkers and rational therapeutic targets","volume":"72","author":"Pietzak","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.jmoldx.2024.01.006_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz3088","article-title":"Analysis of recurrently protected genomic regions in cell-free DNA found in urine","volume":"13","author":"Markus","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jmoldx.2024.01.006_bib34","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1158\/1078-0432.CCR-22-3250","article-title":"Cell-free urine and plasma DNA mutational analysis predicts neoadjuvant chemotherapy response and outcome in patients with muscle-invasive bladder cancer","volume":"29","author":"Christensen","year":"2023","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jmoldx.2024.01.006_bib35","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1093\/annonc\/mdx095","article-title":"Tracking a CAD-ALK gene rearrangement in urine and blood of a colorectal cancer patient treated with an ALK inhibitor","volume":"28","author":"Siravegna","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jmoldx.2024.01.006_bib36","first-page":"1","article-title":"Urine biomarkers of risk in the molecular etiology of breast cancer","volume":"3","author":"Gaikwad","year":"2009","journal-title":"Breast Cancer (Auckl)"},{"key":"10.1016\/j.jmoldx.2024.01.006_bib37","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1373\/clinchem.2008.113050","article-title":"Optimization of transrenal DNA analysis: detection of fetal DNA in maternal urine","volume":"55","author":"Shekhtman","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.jmoldx.2024.01.006_bib38","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1002\/1878-0261.12746","article-title":"TERT C228T mutation in non-malignant bladder urothelium is associated with intravesical recurrence for patients with non-muscle invasive bladder cancer","volume":"14","author":"Hayashi","year":"2020","journal-title":"Mol Oncol"},{"key":"10.1016\/j.jmoldx.2024.01.006_bib39","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1053\/j.gastro.2021.10.038","article-title":"Abnormal TP53 predicts risk of progression in patients with barrett's esophagus regardless of a diagnosis of dysplasia","volume":"162","author":"Redston","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jmoldx.2024.01.006_bib40","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/s41586-019-1856-1","article-title":"Frequent mutations that converge on the NFKBIZ pathway in ulcerative colitis","volume":"577","author":"Kakiuchi","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jmoldx.2024.01.006_bib41","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.juro.2016.06.049","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline","volume":"196","author":"Chang","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.jmoldx.2024.01.006_bib42","doi-asserted-by":"crossref","first-page":"796.e1","DOI":"10.1016\/j.urolonc.2020.04.026","article-title":"Variability in adherence to guidelines based management of nonmuscle invasive bladder cancer among Society of Urologic Oncology (SUO) members","volume":"38","author":"Matulay","year":"2020","journal-title":"Urol Oncol"},{"key":"10.1016\/j.jmoldx.2024.01.006_bib43","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1200\/JCO.18.02052","article-title":"Early detection of metastatic relapse and monitoring of therapeutic efficacy by ultra-deep sequencing of plasma cell-free DNA in patients with urothelial bladder carcinoma","volume":"37","author":"Christensen","year":"2019","journal-title":"J Clin Oncol"}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157824000126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157824000126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T07:37:21Z","timestamp":1710920241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525157824000126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S1525157824000126"],"URL":"https:\/\/doi.org\/10.1016\/j.jmoldx.2024.01.006","relation":{},"ISSN":["1525-1578"],"issn-type":[{"value":"1525-1578","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Clinical Validity of Urinary Pellet DNA Monitoring for the Diagnosis of Recurrent Bladder Cancer","name":"articletitle","label":"Article Title"},{"value":"The Journal of Molecular Diagnostics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmoldx.2024.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Association for Molecular Pathology and American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}